SarcopeniaNCT00907010
Sarcopenia and Aging
An observational study of Sarcopenia, run by Universidade de Franca.
Trial summary
Objective: Evaluate the muscular strength in the ageing process and identify the changes between the abdominal muscles, upper and louver edges. Method: 48 individuals participated in this study, being divided into four groups according to the age: (G1) 11to 18 years old, (G2) 20 to 26 years old, (G3) 45 to 60 years… Read more about this study
- Who is it for?
- Ages 11 to 82 years
- Conditions the study is for
- Sarcopenia
- How many people
- 48 participants
- Where
- No sites listed yet
- Study dates
- Feb 2008to Oct 2008
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 11 to 82 years
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: 48 individuals participated in this study, being divided into four groups according to the age: (G1) 11to 18 years old, (G2) 20 to 26 years old, (G3) 45 to 60 years old and (G4) 66 - 82 years old.
Who may be able to join
- absence of the basic pathology that interferes directly in the muscle
Who cannot join
- people who work out more than three times a week
- severe arthrosin
- stroke
- significant cognitive deficit
- obesity
- use of ortheses for louver members or any break
- with or without metallic implant
About this study
Objective: Evaluate the muscular strength in the ageing process and identify the changes between the abdominal muscles, upper and louver edges.
Method: 48 individuals participated in this study, being divided into four groups according to the age: (G1) 11to 18 years old, (G2) 20 to 26 years old, (G3) 45 to 60 years old and (G4) 66 - 82 years old. The excluding criterion included people who work out more than three times a week, severe arthrosin, stroke, significant cognitive deficit , obesity, use of ortheses for louver members or any break, with or without metallic implant. The evaluation instruments used were: (1) Esfigmomanômetro (EM), (2) Trunk flexor in the supine position,, (3) Jamar Dinamômetro and (4) Preston Pinch Gauge Dinamômetro.
Read the detailed description
Forty-eight subjects participated voluntarily in this work and is divided into four groups of 12 participants with 6 men and 6 women: (G1) 11 to 18 years (G2) 20 to 26 years (G3) from 45 to 60 and (G4) 66 to 82 years, selected in dependency of Unifran and residences of the city of Franca, Sao Paulo - Brazil. To evaluate muscle strength, a BD sphygmomanometer was used to analyze the strength of flexors and extensors of the knee. The Jamar Dynamometer was used to assess the functional integrity of the upper and Preston Pinch Gauge Dynamometer for evaluation of gripper hands.
- Conditions
- Sarcopenia
- Keywords
- Ageing, Sarcopenia, Muscular contraction
- Medical subject headings
- Sarcopenia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Group I | 11 to 18 years - composed of 12 adolescent with six women and six men | |
| Group II | 20 to 26 years - composed of 12 young with six women and six men | |
| Group III | 45 to 60 years - composed of 12 adult with six women and six men | |
| Group IV | 66 - 82 years - composed of 12 aged with six women and six men |
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 May 2009 (estimated)
- Study startFeb 2008
- Primary completionAug 2008
- Study completionOct 2008
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for SarcopeniaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Enrolment
- 48 participants (actual)
Sponsor and investigators
- Lead sponsor
- Universidade de Franca
- Sponsor type
- University, hospital or other
- Investigators
- Lislei Patrizzi, Study director, Universidade de Franca
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00907010
- Sponsor's protocol ID
- 088/08
- Other IDs
- 088/08
- Status last verified
- May 2009
- First submitted
- 19 May 2009
- Last updated
- 21 May 2009
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 21 May 2009. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Sarcopenia and Aging
- ClinicalTrials.gov ID
- NCT00907010
- Acronym / sponsor ID
- 088/08
- Conditions
- Sarcopenia
- Keywords
- Ageing, Sarcopenia, Muscular contraction
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 48 participants (actual)
- Lead sponsor
- Universidade de FrancaUniversity, hospital or other
- Study start
- Feb 2008
- Primary completion
- Aug 2008 (actual)
- Study completion
- Oct 2008 (actual)
- First posted
- 21 May 2009 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Objective: Evaluate the muscular strength in the ageing process and identify the changes between the abdominal muscles, upper and louver edges.
Method: 48 individuals participated in this study, being divided into four groups according to the age: (G1) 11to 18 years old, (G2) 20 to 26 years old, (G3) 45 to 60 years old and (G4) 66 - 82 years old. The excluding criterion included people who work out more than three times a week, severe arthrosin, stroke, significant cognitive deficit , obesity, use of ortheses for louver members or any break, with or without metallic implant. The evaluation instruments used were: (1) Esfigmomanômetro (EM), (2) Trunk flexor in the supine position,, (3) Jamar Dinamômetro and (4) Preston Pinch Gauge Dinamômetro.
Detailed description
Forty-eight subjects participated voluntarily in this work and is divided into four groups of 12 participants with 6 men and 6 women: (G1) 11 to 18 years (G2) 20 to 26 years (G3) from 45 to 60 and (G4) 66 to 82 years, selected in dependency of Unifran and residences of the city of Franca, Sao Paulo - Brazil. To evaluate muscle strength, a BD sphygmomanometer was used to analyze the strength of flexors and extensors of the knee. The Jamar Dynamometer was used to assess the functional integrity of the upper and Preston Pinch Gauge Dynamometer for evaluation of gripper hands.
Study design
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Group I | – | –11 to 18 years - composed of 12 adolescent with six women and six men |
| Group II | – | –20 to 26 years - composed of 12 young with six women and six men |
| Group III | – | –45 to 60 years - composed of 12 adult with six women and six men |
| Group IV | – | –66 - 82 years - composed of 12 aged with six women and six men |
Who may qualify
- Ages
- 11 to 82 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- 48 individuals participated in this study, being divided into four groups according to the age: (G1) 11to 18 years old, (G2) 20 to 26 years old, (G3) 45 to 60 years old and (G4) 66 - 82 years old.
Key inclusion criteria (1 listed)
- absence of the basic pathology that interferes directly in the muscle
Key exclusion criteria (7 listed)
- people who work out more than three times a week
- severe arthrosin
- stroke
- significant cognitive deficit
- obesity
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 May 2009.
Related trials for Sarcopenia
Not yet recruiting
Creatine and Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation Plus Home-Based Exercise for Sarcopenia in Huntington's Disease
Huntington Disease, Sarcopenia
Enrolling by invitation
Physical Activity Interventions for Sleep Improvement and Sedative-Hypnotic Reduction in Middle-Aged and Older Adults: Investigating the Role of Sarcopenia
Insomnia Chronic, Hypnotics and Sedatives
Recruiting
Resistance vs Aerobic Prehabilitation Before Colorectal Cancer Surgery
Colorectal Cancer, Colorectal Neoplasms
Active, not recruitingObservational study
Possible Sarcopenia, Sarcopenia, and Functional Status in Patients With Primary Sjögren's Syndrome
Primary Sjögren Syndrome, Sarcopenia
Not yet recruiting
PROfiles of FGF-19 Post-prandial Secretion in Older Adults With Frailty and Without Frailty
Frailty, Sarcopenia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Lislei Patrizzi study director
Universidade de Franca
Questions about this trial
What is this clinical trial studying?
An observational study of Sarcopenia, run by Universidade de Franca.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 May 2009. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 May 2009.